The document compares the inhibitory effects of three transcriptional variants of the CDKN2A gene in the human lung cancer cell line A549. It finds that p16INK4a has the strongest suppressive effect on cell growth compared to p14ARF and p12. Experiments show p16INK4a, p14ARF, and p12 are expressed in A549 cells and lead to cell cycle arrest before DNA replication in the S phase. Protein transduction of the transcriptional variants into A549 cells demonstrates their tumor suppressive effects and potential for protein therapy.
CDKN2A variants inhibitory effects lung cancer A549
1. Manuela Parra Cardona 3rd Semester Medicine student Texto adicional Texto adicional Texto adicional texto adicional Texto adicional texto adicional Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549 Wei Zhang ( Laboratory of Medical Genetics, Harbin Medical University) Journal of experimental & clinical cancer research
2.
3. GENERAL OBJETIVE Compare the inhibitory effects of the three transcriptional variants of CDKN2A in human lung cancer cell line A549 with endogenous expression deficiency. Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549
4. CANCER Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549
6. TRANSCRIPTION It is the molecule that carries genetic information (from DNA) to the cytoplasm for the production of proteins. RNA POLYMERASE http://www.google.com.co/imgres?imgurl=http://www.genome.gov/Images/EdKit/bio2c_large.gif&imgrefurl=http://www.genome.gov/EdKit/bio2c.html Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549
7. LUNG CANCER Occurs when cells in the lung, change to become abnormal. Types of Lung Cancer There are 2 main types of lung cancer. • Non-Small Cell Lung Cancer This is the most common type of lung cancer. • Small Cell Lung Cancer http://www.google.com.co/imgres?imgurl=http://www.newhopeblog.com/Lung%2520cancer.jpg Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549
8. CDKN2A Tumor suppressor gene, that encodes proteins whit tumor suppressor activity P16INK4a, P14ARF and P12. It is a specific cell cycle regulator of G1 stage, that inhibits the CDK4 and CDK6 thereby inhibits the phosphorylation or pRB. P16INK4a Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549
9. P14ARF regulates tumor protein 53 (p53) activity by inhibiting MDM2, a ubiquitin ligase that otherwise targets p53 for degradation by proteasome. DNA damage and other signs of stress can cause the release of p53 and increase its concentration, allowing to perform its role as a transcription factor. P14ARF MDM2 P53 P53 degradation Arrest of cell cycle Normal cell cycle Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549
10.
11.
12. CULTIVO CÉLULAR F12-K con FBS (fetal bovine serum) Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549
13. RT-PCR Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549 RNA TRANSCRIPTAS INVERSA DNAc AGZY H446 y células pancreáticas (expresión) DNAc de P16, P14 y P12
14.
15. INMUNOHISTOQUÍMICA permiten la identificación, sobre muestras tisulares, la localización de una molécula de interés. Mediante anticuerpos marcados y diseñados para reconocer dicha molécula. Evaluar la expresión de P!6, P14 y P12 Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549
16. CITOMETRIA DE FLUJO Es el análisis de las características de células, Donde las células pasan alineadas una a una frente a un haz láser mediante un flujo continuo. Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549 En el estudio…. Evaluaron el estadio en el cual se encontraban del ciclo celular, después de la expresión de p16, p14 y p12.
17.
18. RT-PCR of A459 Expression of P16INK4a, P14ARF and p12 were confirmed. 543 bp 493 bp 372 bp P16INK4a P14ARF P12
20. Citometria de flujo Comparación de la inhibición de crecimiento celular que cada proteína obtuvo, en el último día de conteo celular.
21. En el estudio … Antes del IPTG Después de IPTG y centrifugación Abundante en sobrenadante Solo sobrenadante (sin precipitado bacteria) Se muestra proceso de purificación de proteínas con Imidazol. Proteína blanco (p16) a los 100mM de imidazol mejor purificación de la proteína recombinante del interés
22.
23. Agree Agree Agree Agree Author What he said Check Bai-qiu W, Cheng-hui “ Previous research in our laboratory also demonstrated that introduction of p16INK4a neither suppresses growth nor decreases colony formation rates by Anip973 and AGZY83-a cells expressing endogenous wild-type p16INK4a.” Yi-zhao C, Rui-xiang X “ Transient p16INK4a transfection induces apoptosis whereas stable transfection markedly suppresses cell growth and cloning Efficiency” Robertson KD, Jones PA “ p12 cannot bind cyclin-dependent kinase CDK4 and acts in a pRb- independent manner” Harbour JW, Worley L, Sun J, Yan Y, Wang XT The administration of protein therapeutic agents has proved to be feasible and effective both in vitro and in vivo